Cerebral Therapeutics

About:

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Website: http://www.cerebraltherapeutics.com/

Top Investors: RA Capital Management, Perceptive Advisors, Vivo Capital, Granite Point Capital, Lynx1 Capital Management

Description:

Cerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy.

Total Funding Amount:

$85.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Aurora, Colorado, United States

Founded Date:

2010-01-01

Founders:

Daniel J. Abrams

Number of Employees:

1-10

Last Funding Date:

2022-06-28

IPO Status:

Private

Industries: